Mayne reacts to HRT black box move
MAYNE Pharma has reacted to the US Food and Drug Administration’s (FDA) announcement that it will remove “black box” warnings…
$1m for mini tumours
A WA researcher has been awarded almost $1 million in funding to investigate tiny lab-grown tumours to help find treatments…
Dispensary Corner 18 Nov 25
APART from negatively impacting the planet through rising global temperatures and extreme weather events, it has now been revealed that…
Action needed as AMR in the spotlight
AS WORLD AMR Awareness Week (WAAW) launches today, stakeholders and policymakers who play a critical role in reducing the spread…
Heart disease no longer #1 killer
DATA released last week by the Australian Bureau of Statistics (ABS) has named dementia as the leading cause of death…
Chronic disease socio-economic link complex
AN ANALYSIS of 2021 Australian census data has shown that socioeconomic position is a major risk factor for chronic disease,…
Is a cure for asthma in the pipeline?
A NEW Medical Journal of Australia supplement sets out the first evidence-based roadmap for curing asthma, with AI, epigenetics and…
Back the bid
GLUCOJEL has teamed up with Netball Australia in its bid for the game’s inclusion at the Brisbane 2032 Olympics. By…
Maximise your day
NEW Maxofen from Nova Pharmaceuticals combines paracetamol and ibuprofen for double-action relief from acute pain and fever. Available in packs…
Call for action on migrant health
RESEARCH commissioned by healthcare group Bupa has found that migrants in Australia face systemic barriers to healthcare, including confusing and…